USFDA completes inspection at Divi’s Laboratories’ Unit-II facility in Andhra Pradesh

01 Feb 2020 Evaluate

US Food and Drug Administration (USFDA) has completed inspection at Divi’s Laboratories’ Unit-II, Village Chippada, Bheemunipatnam District in the state of Andhra Pradesh. The inspection was conducted from January 27 to 31, 2020. The inspection has been concluded with no ‘483’ observations.

Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry.

Divis Lab Share Price

6307.85 -86.80 (-1.36%)
01-Jan-2026 14:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.60
Dr. Reddys Lab 1250.85
Cipla 1499.55
Zydus Lifesciences 912.55
Lupin 2101.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×